Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Long-Term Safety of Tocilizumab in Patients with Rheumatoid Arthritis and a Mean Treatment Duration of 3.7 Years. Genovese, M. C., Sebba, A., Rubbert-Roth, A., Jose Scali, J., Alten, R., Kremer, J. M., Pitts, L., Vernon, E., van Vollenhoven, R. F. WILEY-BLACKWELL. 2012: S700–S701
View details for Web of Science ID 000309748303361